Shots:
Samsung Biologics’ US subsidiary entered a definitive agreement to acquire 100% of Human Genome Sciences from GSK, securing its first US based manufacturing site in Rockville, Maryland
As per the deal terms, Samsung Biologics will acquire the Rockville assets for $280M, with closing expected by end of Q1’26, while retaining 500+ employees to ensure…
Shots:
CDMOs have become central to the modern biopharmaceutical ecosystem, helping companies accelerate development timelines, navigate rising technical complexity, and bring innovative therapies to market with greater efficiencyÂ
The global CDMO market continues to post strong double-digit growth and is projected to reach nearly $255B by 2025. This momentum is driven by increased outsourcing, the…
Shots:
Pharmaceutical manufacturing involves complex procedures like blending, compression, filtration, heating, encapsulation, shearing, tableting, granulation, coating, and drying. Traditionally, for all these processes, pharma companies had designated factory floors to carry out the process smoothlyÂ
The flexible manufacturing system (FMS) revolutionized the course of manufacturing, especially in the pharma industry. Contract Development Manufacturing Organizations' (CDMOs)…
The first quarter of 2022 highlights the approvals, clinical data & acquisitions. There are major alliances in this quarter which include Biocon acquired Viatris’ biosimilars assets for ~$3.335B, Stryker signed a definitive agreement to acquire Vocera Communications for ~$3.09B, Biohaven acquire Channel Biosciences for ~$3B
The first quarter of the year also showcases regulatory events…

